Objective: To observe the short-term and long-term influences of nasal continuous positive airway pressure (nCPAP) to sleep architecture of obstructive sleep apnea hypopnea syndrome (OSAHS).

Methods: Thirty cases who were diagnosed as OSAHS patients by polysomnography (PSG) were enrolled in the study. They received the nCPAP treatment in hospital at first night and then at home. Seventeen healthy adults were enrolled as control group and experienced PSG monitoring and recording. The sleep architectures of control group and OSAHS group (before nCPAP, first night on the nCPAP and 6 months after continuous nCPAP treatment) were analysed.

Results: The sleep shift number, first stage sleep, second stage sleep, stage of slow wave sleep and stage of rapid eye movement (REM) sleep were 34.41 +/- 10.16, (5.95 +/- 3.89)%, (48.13 +/- 7.68)%, (18.30 +/- 4.71)%, and (26.83 +/- 6.65)%, respectively, in control group. These parameters in OSAHS group before nCPAP were 207.30 +/- 149.80, (21.42 +/- 10.17)%, (55.24 +/- 13.28)%, (15.38 +/- 19.57)%, and (10.15 +/- 7.82)%, respectively. At the first night of nCPAP treatment they were 55.77 +/- 25.04, (10.92 +/- 9.62)%, (50.19 +/- 13.34)%, (17.53 +/- 10.06)%, and (21.17 +/- 7.66)%, respectively. There were statistically significant differences between the PSG parameters before and after nCPAP treatment in OSAHS group (P < 0.05). After 6 months of nCPAP treatment, the stage of REM sleep was significantly shorter (P < 0.05), but the other parameters had no significant changes compared with those at the first night on nCPAP (P > 0.05).

Conclusion: The sleep shift number and first stage sleep in OSAHS group were significantly increased, but the stage of REM sleep was significantly decreased than those in control group. The sleep architecture of OSAHS was significantly improved when the nCPAP treatment was given continuously.

Download full-text PDF

Source

Publication Analysis

Top Keywords

ncpap treatment
24
control group
16
osahs group
16
sleep
15
+/-
15
sleep architecture
12
night ncpap
12
stage sleep
12
rem sleep
12
ncpap
11

Similar Publications

Background: Respiratory Distress Syndrome (RDS) is the most common complication of preterm neonates. It remains one of the major public health concerns that contribute to neonatal mortality and morbidity, especially in Africa, where 80% of neonatal mortality is estimated to be caused by preterm complications. Nasal Continuous Positive Airway Pressure (NCPAP) ventilation is the preferred mode of RDS treatment.

View Article and Find Full Text PDF

Background: Nasal continuous positive airway pressure (NCPAP) is widely used for premature infants with respiratory distress syndrome (RDS). A high-flow nasal cannula (HFNC) provides positive end-expiratory pressure using high-flow oxygen; however, the variability in distending pressure is a primary concern. This study evaluated the feasibility and safety of a newly designed protocol for NCPAP weaning with cyclic HFNC use for premature infants.

View Article and Find Full Text PDF

Nasal continuous positive airway pressure inhibits gastroesophageal refluxes in the preterm lamb.

Am J Physiol Gastrointest Liver Physiol

December 2024

Neonatal Respiratory Research Unit, Departments of Pediatrics and Pharmacology-Physiology, University of Sherbrooke, Sherbrooke, Quebec, Canada.

Gastroesophageal refluxes (GERs) are universal in newborns and may induce deleterious consequences, especially in preemies. We have previously shown that nasal continuous positive airway pressure (nCPAP) inhibits GERs in full-term lambs, complementing similar results in adult humans. The effect of high-flow nasal cannula (HFNC) on GERs, however, remains unknown.

View Article and Find Full Text PDF

Background: The aim of this study is to investigate and compare the effects of administering a surfactant through a fine intra-tracheal catheter during spontaneous breathing with the usual INSURE method in premature infants.

Materials And Methods: In this clinical trial, premature babies with respiratory distress syndrome who required surfactant administration were randomly assigned to two groups: an intervention group (MIST) and a control group (INSURE). The treatment results were compared in terms of complications related to treatment (desaturation, apnea, bradycardia, and surfactant reflux), respiratory complications (requirement for mechanical ventilation, duration of nCPAP, duration of oxygen requirement, frequency of pneumothorax, and pulmonary hemorrhage), complications related to prematurity (incidence of IVH, NEC, BPD, and PDA), the need for a second dose of surfactant, and the duration of hospitalization.

View Article and Find Full Text PDF

Background: Noninvasive neurally-adjusted ventilatory assist (NIV-NAVA) improves patient-ventilator synchrony and may reduce treatment failure in preterm infants compared with nasal continuous positive airway pressure (NCPAP) and noninvasive positive-pressure ventilation (NIPPV). We conducted a systematic review and meta-analysis to assess the effects of NIV-NAVA in preterm infants with respiratory distress.

Methods: Four investigators independently assessed the eligibility of studies in CENTRAL, CINAHL, ClinicalTrials.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!